used as an animal model. 6 In this study, we investigated the impact of sucrose gel on the vaginal microbiota of rhesus macaques to elucidate the mechanism of sucrose gel in the treatment of BV patients.
Materials and Methods

Intervention, animal model and sample collection
The sucrose and placebo gels were produced as previously reported. 1 Briefly, the main ingredient of the placebo gel was xanthan gum, and the sucrose gel was prepared by adding 9% sucrose to the placebo gel. All animal studies were approved by the Institutional Animal Care and Use Committee (IACUC), Nanshan Hospital, Guangdong Medical College. Female rhesus macaques were provided by West China-Frontier PharmaTech Co.
(WCFP)/National Chengdu Center for Safety Evaluation of Drugs (NCCSED), SPF (specific pathogen free), and were approximately four years of age. Female rhesus macaques were included in the study when vaginal conditions satisfied the criteria of human BV diagnosis, including a baseline Nugent score >4, a high vaginal fluid pH (>4.8), few or lack of (1) leukocytes, (2) lactobacilli, (3) Candida. After eliminating any data collected from menstruating rhesus macaques, the sucrose gel group contained 16 monkeys, and the placebo gel group contained three. Female rhesus macaques in the sucrose gel group were administered with the gel by syringe to the fornix of the vagina for five consecutive days while the placebo gel group was administered with the placebo gel. On study days one to six, vaginal samples were collected daily to evaluate the Nugent score and measure pH levels. Vaginal smears were observed by microscopy. Separate vaginal swabs were collected for pH measurements and microscopy grading examination.
Swab samples and DNA extraction
On study days one and six, quadruplicate vaginal swab specimens were obtained and stored at -80 8C for 16S rDNA V3$V4 metagenomic sequencing and qPCR analysis. The head of the sterile cotton swab collected for each specimen was cut and placed into an eppendorf tube containing 1 mL PB. The tubes were centrifuged for 10 min at 10,000 g to collect bacterial cells, and the supernatant was discarded. Genomic DNA extraction was performed using the QIAamp DNA mini kit (Qiagen, Germany) as described. 7 
Illumina MiSeq sequencing, sequence processing and classification
The concentration of total DNA extracted from the vaginal swabs was measured using a High Sensitivity Qubit (Life Technologies Corporation, Carlsbad, CA). For each sample, three 50ul PCR mixes were prepared. The V3$V4 region of the 16S rDNA was then amplified through a polymerase chain reaction (PCR) as previously reported. 8, 9 The samples and the negative template control were then analyzed on an agarose gel (1% w/v in TAE buffer) for quality control. The three PCR reactions were pooled and 45 mL of each pooled PCR reaction was purified using Agencourt
AMPure beads (Beckman Coulter, CA) according to the manufacturer's instructions, with a final elution in 15 mL of 10Â TE buffer.
DNA concentration was measured using a Qubit kit (Invitrogen, California, USA). The sample concentrations were adjusted and the same total amount of each sample was used to perform Illumina MiSeq sequencing with a standard amplicon kit according to the 300PE MiSeq protocol. 9 300PE reads were further processed, including denoising by clustering sequences with less than 3% dissimilarity using USEARCH 10 and de novo chimera detection, conducted with UCHIME v5. 
Quantitative Lactobacillus genus-specific real-time PCR Assays
The dynamic changes of the Lactobacillus genus as influenced by sucrose were examined by quantitative PCR using a Lactobacillus genus-specific forward primer (5 0 -TGGAAACAGRTGCTAATACCG-3 0 ) and reverse primer (5 0 -GTCCATTGTGGAAGATTCCC-3 0 ) as previously reported to quantify the copy number of Lactobacillus 16S rDNA in each sample.
14 DNA was extracted as described above.
Each SybrGreen qPCR reaction mixture contained SybrGreen qPCR
Master Mix (2Â; ABI, USA), 12.5 mL (10 mM) each of forward and reverse primers, and 1 mL of template DNA in a total volume of 25 mL. The thermocycling conditions for SybrGreen qPCR assays were 95 8C for 10 min, followed by 25 cycles of 95 8C for 10 sec and 60 8C for 40 sec, with a fluorescence read at 60 8C followed by a melting curve analysis. The entire process was conducted on an ABI StepOnePlus Real-Time PCR instrument. For the relative quantification of Lactobacillus genus, genomic DNA from L. fermentum was extracted and quantified using a Qubit Kit (Invitrogen). The PCR product from L. fermentum was used as positive control after gel purification and DNA sequencing verification. Standard curves were generated using five 10-fold dilutions of L. fermentum DNA which ranged from 2.58Â10 4 to 2.58Â10 8 copies/mL. Assay results were expressed as genome/gene lg10 copy numbers per 1 mL of DNA. Negative controls were included in each PCR run.
Statistical analysis
Data were analyzed using IBM statistical SPSS 2.0 software. Differences in bacteria scores (Table S1-S3) before and after treatment were compared using the Mann-Whitney U Test. Differences in the proportion of Lactobacillus DNA in all sequences and the FQPCR assay result of the number of Lactobacillus DNA lg copies before and after the treatment were compared using a paired T test. A P value of less than 0.05 was considered to be statistically significant.
Results
Vaginal pH detection and microscopy grading
The vaginal pHs of animals treated with sucrose gel decreased to below 4.6 in 14/16 animals by day three and by day five the decrease was observed in all treated animals. In contrast, the vaginal pHs of the placebo gel group rhesus macaques stayed above 4.8 following treatment. Prior to treatment, the relative abundance of non-lactobacilli bacteria (G.vaginalis, bacteroides and Mobiluncus spp. morphotypes) dominated the vaginal flora of all rhesus macaques based on Nugent scores, suggesting a depletion of lactobacilli in these models. By day five of sucrose gel treatment, however, the number of lactobacilli gradually increased and dominated the vaginal flora (Fig 3A) . Furthermore, the lactobacilli score of the sucrose gel group was significantly lower than before treatment (P < 0.001, Table S1), and the G. vaginalis/bacteroides and Mobiluncus score before treatment was higher than after treatment (P < 0.001 and P < 0.05, respectively, Table S2 and S3). Based on the Nugent scoring system, 93.8% (15/16) of the vaginal flora of the sucrose gel group became ''normal'' (Nugent score < 4) according to the human criteria, suggesting that sucrose facilitates the propagation of lactobacilli in the vaginal region. In contrast, the placebo gel groups maintained pre-treatment characteristics with regard to the bacteria morphotypes and constitutions of vaginal flora (Fig 3B) and showed no significant difference in Nugent score (P > 0.05) following placebo gel treatment. This result confirmed that sucrose was effective and critical in the reconstruction of ''normal vaginal flora'' in the animal models of BV.
Composition of vaginal microbiota as determined by Illumina Miseq sequencing
Taxonomic composition of the vaginal microbiota in the sucrose gel and control groups was investigated based on average relative abundance of Illumina MiSeq sequencing reads assigned to phylum (Fig 1, chart A) and genus (Fig 1, chart B) . The proportion of different kinds of bacterial genus is shown in detail in Fig  2. Before the treatment, the charts indicate a diverse array of vaginal bacteria in the rhesus macaques, with abundant genera and Lactobacillus representing less than 2% of all sequences. Following 5 days of vaginal application of sucrose gel, Lactobacillus dominated the vaginal flora with 50.84% to 96.98% of sequences identified as Lactobacillus. The relative abundance of Lactobacillus in vaginal samples in the placebo gel group did not increase after treatment, ranging from 0.06% to 10.96%.
Lactobacillus 16S rDNA copies in vaginal specimens
As shown in Figure S1 , after 5 days of sucrose gel treatment, the copy number of Lactobacillus in the sucrose gel treatment group increased from 4.45 AE 0.71 lg copies/mL to 6.02 AE 0.30 lg copies/mL after treatment, demonstrating a significant increase (pair T test, t = 7.702, P < 0.01). In contrast, the number of Lactobacillus DNA copies in vaginal samples from the placebo gel group did not increase after treatment.
Discussion
The vaginal flora of rhesus macaques is characterized by a polymicrobial microbiota. It is also suitable for growth of lactobacilli including L. crispatus, L. jensenii and L. acidophilus, which also colonize the human vagina.
6, 15 Gregory and colleagues found that the vaginal microbiota of rhesus macaques was similar to the flora found in BV patients. 16 In this study, we examined the vaginal microbiota of rhesus macaques based on the Nugent score standard which is widely used to define BV. Our Illumina MiSeq sequencing results in these animals before treatment further demonstrated that the vaginal microbiota was similar to that in BV patients, suggesting they could be used as animal models of BV. Traditionally, metronidazole is used in BV treatment. 16 As an antibiotic, however, metronidazole inherently possesses the risks of adverse effects and the potential risk of bacterial drug resistance. [17] [18] [19] [20] The sucrose gel is, therefore, a novel non-antibiotic for treatment of BV. Phase III clinical trials have shown its potential role in treating BV. It may regulate the vaginal flora of rhesus macaques and facilitate the growth of Lactobacillus spp to obtain a ''normal vaginal flora''. 1 In this study, we demonstrated that sucrose could decrease the vaginal pH and alter the bacterial composition of the vaginal microbiota in an animal model. The Illumine MiSeq system provides a powerful sequencing platform for the rapid, high-throughput and in-depth characterization of the microbial community composition using 16S rDNA gene V3$V4 region sequencing. 9 The relative abundance of Lactobacillus DNA in the sucrose gel treatment group ranged from 50.84% to 96.98%, significantly increased (P < 0.01) compared with the percentage ranging from 0.06% to 10.96% before treatment. In contrast, the relative abundance of Lactobacillus DNA in the control group did not change. Lactobacilli plays an important role in the human vaginal flora and is thought to be significant in maintaining the vaginal health of women owing to their probiotic characteristics in inhibiting the growth of many pathogens including anaerobic bacteria, fungi and viruses by competitive exclusion and/or through the production of antimicrobial compounds, such as reuterin, organic acids and/or hydrogen peroxide. 15 Our data indicate that sucrose may facilitate the growth of lactobacilli. Sucrose can also be utilized by many bacteria in the vaginal region; however, in this study, there was no increase in other bacteria following the sucrose intervention, suggesting that sucrose advantageously promotes the growth of lactobacilli. We hypothesize that, in the conditions found in the vagina, lactobacilli can more effectively use sucrose. Why lactobacilli have this advantage, however, requires further study. Overall, our study indicates that rhesus macaques can be used as BV animal models to develop drugs and test treatment efficacy. Sucrose gel showed good efficacy in this model to treat BV by improving the Nugent Score and vaginal microbiota by promoting growth of Lactobacillus species. Further studies need to be performed to determine the mechanism by which lactobacilli preferentially propagate in the presence of sucrose.
